Showing 1 - 6 results of 6 for search 'Marc Masanas', query time: 0.02s
Refine Results
-
1
The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome by Cinthia Aguilera, Stefan Hümmer, Stefan Hümmer, Marc Masanas, Elisabeth Gabau, Miriam Guitart, A. Arockia Jeyaprakash, Miguel F. Segura, Anna Santamaria, Anna Ruiz
Published 2021-05-01
Article -
2
Long Non-coding RNA PVT1 as a Prognostic and Therapeutic Target in Pediatric Cancer by Ariadna Boloix, Ariadna Boloix, Ariadna Boloix, Marc Masanas, Carlos Jiménez, Roberta Antonelli, Aroa Soriano, Josep Roma, Josep Sánchez de Toledo, Soledad Gallego, Miguel F. Segura
Published 2019-11-01
Article -
3
Neuronal Differentiation-Related Epigenetic Regulator <i>ZRF1</i> Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro by Carlos Jiménez, Roberta Antonelli, Marc Masanas, Aroa Soriano, Laura Devis-Jauregui, Jessica Camacho, Ainara Magdaleno, Gabriela Guillén, Raquel Hladun, Luz Jubierre, Josep Roma, David Llobet-Navas, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego, Miguel F. Segura
Published 2021-09-01
Article -
4
FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b by Elena Coccia, Elena Coccia, Elena Coccia, Marc Masanas, Joaquín López-Soriano, Joaquín López-Soriano, Joaquín López-Soriano, Miguel F. Segura, Joan X. Comella, Joan X. Comella, Joan X. Comella, M. José Pérez-García, M. José Pérez-García, M. José Pérez-García
Published 2020-12-01
Article -
5
Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program by Carlos Jiménez, Roberta Antonelli, Mariona Nadal-Ribelles, Laura Devis-Jauregui, Pablo Latorre, Carme Solé, Marc Masanas, Adrià Molero-Valenzuela, Aroa Soriano, Josep Sánchez de Toledo, David Llobet-Navas, Josep Roma, Francesc Posas, Eulàlia de Nadal, Soledad Gallego, Lucas Moreno, Miguel F. Segura
Published 2022-09-01
Article -
6
The oral KIF11 inhibitor 4SC‐205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models by Marc Masanas, Nuria Masiá, Leticia Suárez‐Cabrera, Mireia Olivan, Aroa Soriano, Blanca Majem, Laura Devis‐Jauregui, Rebeca Burgos‐Panadero, Carlos Jiménez, Pau Rodriguez‐Sodupe, Ariadna Boloix, Ignasi Toledano, Gabriela Guillén, Alexandra Navarro, David Llobet‐Navas, Alberto Villanueva, Josep Sánchez de Toledo, Josep Roma, Rosa Noguera, Lucas Moreno, Rolf Krauss, Soledad Gallego, Anna Santamaria, Miguel F. Segura
Published 2021-10-01
Article